Protein USP25 linked to cellular senescence via SIRT1 in mice
Aging cells accumulate in the body and cause damage. Researchers have found a molecular switch that controls this process, and developed a short peptide that can block it.
As cells age, they can enter a stable non-dividing state known as cellular senescence. These cells no longer divide, but they release signalling molecules that can harm surrounding tissue. An excess of senescent cells is associated with accelerated aging. How this process is regulated at the molecular level is not fully understood. New research published in the journal Aging Cell identifies a protein called USP25 as a key regulator, acting through SIRT1, a well-known controller of cellular aging.
USP25 suppresses SIRT1 and accelerates senescence
The researchers found that USP25 binds directly to SIRT1 and reduces its activity through a chemical modification called deubiquitination. Lower SIRT1 activity in turn increases acetylation of other proteins, including p53 and PGC1α, accelerating the transcription of senescence signals. Mice lacking USP25 showed fewer age-related physical changes and better overall physiological function.
Building on this mechanism, the team developed a short peptide called pSirt1-4 that disrupts the USP25-SIRT1 interaction. In cell experiments, the peptide increased SIRT1 activity and reduced the production of senescence signals. The researchers describe the USP25-SIRT1 axis as a promising therapeutic target for treating senescence-related diseases.
Important caveats
An open question is whether blocking this ageing process in cells would also interfere with protective forms of it, such as during wound healing. Similar approaches using enhanced cellular self-cleaning, such as rapamycin, appear safe in this regard in mice. Whether the USP25-SIRT1 connection behaves the same way remains unknown and requires further investigation.
Search terms to explore further: SIRT1 deacetylase cellular senescence, deubiquitination protein regulation, senostatic therapy aging